Before the headlines hit about the dangers of using Vioxx (rofecoxib), researchers were already aware, say news reports.
Vioxx, a non-steroidal anti-inflammatory (NSAID), was made by Merck & Co. Inc., and introduced to the American market in 1999. The company then voluntarily pulled the drug from the market in September 2004, after there were multiple reports of increased risk of heart attack and stroke associated with long-term, high-dose use.
Six investigators from the Mount Sinai School of Medicine analyzed 30 randomized placebo-controlled trials involving Vioxx  and 20,152 individuals. They published their findings in the November 23 issue of Archives of Internal Medicine.
What …read more

It’s the weekend, so that means a weekly round-up of the most popular posts. Here we are:

Topical NSAID As Effective As Tablets For Knee Pain
Numbing gel eases pain from mammograms
Pregnancy and migraines
The pain of pleurisy
Company’s calling: For Grace’s founder, Cynthia Toussaint speaks out
Legitimate patients with chronic pain vs drug seekers
Gastric bypass/kidney stone connection?
10 causes of chronic pain in seniors
Ticks that cause Lyme disease found in new regions across Canada
A blogger tells how leg pain signaled ovarian cancer

What do you think of those choices? Do any of them surprise you as being popular?
~~~